Published in Hepatitis Weekly, September 4th, 2006
"Rituximab, an anti-CD20 monoclonal antibody, has been used in lupus nephritis and membranous idiopathic nephropathy and has proved effective in non-renal manifestations of type II MC syndrome. We investigated the possible efficacy and safety of rituximab in the treatment of cryoglobulinaemic nephritis," wrote L. Quartuccio and colleagues, University of Udine.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.